While there are only a couple of studies investigating glucose-dependent insulinotropic polypeptide (GIP) and glucagon levels in acromegaly, there are no studies documenting the alterations in glucagon like peptide-1 (GLP-1) levels in patients with acromegaly23,24. This evidence concerns the gene GIP and acromegaly.